Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Airbnb
TI
TickerTickle
Community Contributor
Airbnb (ABNB): Still one of the most interesting bets in travel
Key insights Airbnb is changing from a travel-only app to a full lifestyle platform (stays, rentals, experiences) International markets are growing faster than the US, which is slowing down Product experience is improving a lot, with AI making search and booking easier Regulations are becoming a big risk, especially in Europe where listings are getting removed The way people move around the world has changed. It’s not only about holidays anymore.
View narrative
US$163.75
FV
23.6% undervalued
intrinsic discount
12.00%
Revenue growth p.a.
Set Fair Value
11
users have liked this narrative
2
users have commented on this narrative
42
users have followed this narrative
New
narrative
ING Groep
PI
PittTheYounger
Community Contributor
ING leads the pack when it comes to pivoting towards non-lending income
ING, of course, is a bank; and banks don't like falling interest rates, right? For the dominant stream of income is their core business model, i.e. borrowing short-term and lending long-term, reaping the difference in interest rates in the process.
View narrative
€27.92
FV
23.7% undervalued
intrinsic discount
9.00%
Revenue growth p.a.
Set Fair Value
5
users have liked this narrative
0
users have commented on this narrative
15
users have followed this narrative
New
narrative
Coles Group
RO
Robbo
Community Contributor
Coles (ASX: COL): Safe, Steady, and Surprisingly Cheap
The supermarket chain Coles is the kind of “boring” business that may have been overlooked as an investment opportunity. Although it was divested from Wesfarmers in 2018, Coles’ heritage traces back to 1914 — giving it over 110 years of history.
View narrative
AU$22.00
FV
4.3% undervalued
intrinsic discount
8.72%
Revenue growth p.a.
Set Fair Value
5
users have liked this narrative
2
users have commented on this narrative
16
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Ambarella
AN
AnalystLowTarget
Consensus Narrative from 12 Analysts
Geopolitical Strain And Chip Rivalry Will Undermine Future Value
Key Takeaways Geopolitical risks and industry shifts threaten supply chain stability, cost structure, and market position, leading to heightened unpredictability in revenues and margins. Growing competition and customer self-sufficiency undermine pricing power and profitability, while reliance on core markets and R&D spending heighten financial vulnerability.
View narrative
US$50.02
FV
33.9% overvalued
intrinsic discount
12.36%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
about 10 hours ago
author updated this narrative
PROCEPT BioRobotics
AN
AnalystLowTarget
Consensus Narrative from 9 Analysts
Competitive Pressures Will Hinder Urologic Procedures Yet Spur Progress
Key Takeaways Growth potential driven by demographic trends and innovation faces threats from competition, pricing pressure, and possible market shifts to non-device treatments. Expansion and recurring revenue are promising, but high costs, reimbursement risks, and geopolitical factors could constrain margins and profitability.
View narrative
US$51.00
FV
18.5% undervalued
intrinsic discount
26.48%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
about 10 hours ago
author updated this narrative
Ultragenyx Pharmaceutical
AN
AnalystLowTarget
Consensus Narrative from 20 Analysts
Rising Clinical Risks Will Depress Biotech Pipeline Yet Invite Rebound
Key Takeaways Ultragenyx's promising late-stage pipeline and orphan drug approvals face significant risks from clinical setbacks, pricing pressures, and high R&D costs, impacting future profitability. Heavy reliance on a limited product portfolio, potential biosimilar competition, and challenges in global commercialization threaten long-term revenue growth and margin expansion.
View narrative
US$38.23
FV
22.3% undervalued
intrinsic discount
14.08%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
about 10 hours ago
author updated this narrative
PTC Therapeutics
AN
AnalystLowTarget
Consensus Narrative from 16 Analysts
Rising Healthcare Cost Containment And Delayed Approvals Will Erode Margins
Key Takeaways Increasing regulatory delays, pricing constraints, and competition threaten PTC's ability to profitably launch and sustain new rare disease therapies. Reliance on a shrinking product portfolio and persistent cash burn heighten the risk of revenue decline and potential shareholder dilution.
View narrative
US$44.00
FV
11.0% overvalued
intrinsic discount
-21.56%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
about 10 hours ago
author updated this narrative
Somany Ceramics
AN
AnalystLowTarget
Consensus Narrative from 15 Analysts
Expensive Retrofitting And Shifting Market Demand Will Depress Margins
Key Takeaways Shifts in regulations, consumer preferences, and rising costs are straining margins, pressuring earnings, and threatening market relevance for traditional ceramic products. Overcapacity, domestic market dependence, and distributor consolidation hinder revenue growth potential and weaken the company's long-term financial stability.
View narrative
₹470.00
FV
8.7% overvalued
intrinsic discount
8.11%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
about 10 hours ago
author updated this narrative
Seven West Media
AN
AnalystLowTarget
Consensus Narrative from 9 Analysts
Declining Broadcast Revenues And Soaring Legacy Costs Will Hamper Outlook
Key Takeaways Declining traditional advertising and shifting audience habits threaten revenue growth, while digital gains are insufficient to offset structural declines. High operating costs, strong global competitors, and tougher regulations will squeeze margins and hinder long-term earnings recovery.
View narrative
AU$0.13
FV
11.5% overvalued
intrinsic discount
0.66%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
about 10 hours ago
author updated this narrative
ABB
AN
AnalystLowTarget
Consensus Narrative from 22 Analysts
Global Protectionism And Rising Cost Burdens Will Erode Margins
Key Takeaways Global protectionism, local competition, and commodity price pressures threaten ABB's revenue growth, margins, and ability to maintain cost advantages. Portfolio complexity and ongoing restructurings heighten risks of integration issues and underperformance, potentially harming profitability and long-term earnings.
View narrative
CHF 38.29
FV
40.7% overvalued
intrinsic discount
3.34%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
about 10 hours ago
author updated this narrative
Tourism Holdings
AN
AnalystLowTarget
Consensus Narrative from 3 Analysts
Rising Carbon Taxes And Aging Demographics Will Erode Margins
Key Takeaways Environmental regulation, demographic shifts, and geopolitical risks threaten long-term demand, operational costs, and revenue stability for Tourism Holdings. Disruptive mobility trends and lagging vehicle sales undermine the relevance and profitability of its traditional RV business model, increasing margin compression risk.
View narrative
NZ$1.55
FV
43.9% overvalued
intrinsic discount
4.50%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
about 10 hours ago
author updated this narrative
S4 Capital
AN
AnalystLowTarget
Consensus Narrative from 8 Analysts
Margin Squeeze And Revenue Drag Will Persist Yet Offer Hope
Key Takeaways Heavy client concentration in volatile sectors, combined with brands adopting in-house AI tools, threatens revenue stability and undermines growth potential. Persistent high staff costs and intensified data privacy regulations challenge operational efficiency and curtail margin and revenue improvement.
View narrative
UK£0.27
FV
20.7% undervalued
intrinsic discount
-4.89%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
about 10 hours ago
author updated this narrative
Value any company in seconds
Popular companies